Marshall Wace North America’s Kalaris Therapeutics KLRS Stock Holding History

Marshall Wace North America’s Portfolio KLRS Stock Details KLRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$8.14M	Hold
2021 Q2	$6.41M	Sell
2021 Q1	$7.68M	Buy
2020 Q4	$12.5M	Sell
2020 Q3	$16M	Buy